Innovators in Science Award – Rare Diseases – Early Career Solicitation

Program Summary 

The 2020 Innovators in Science Award recognizes a promising Early-Career Scientist’s research in Rare Diseases, and is intended to support their commitment to innovative research. The winning scientist will have distinguished themselves for the creativity and impact of their research.


CU Internal Deadline: 11:59pm MST October 7, 2019

Sponsor Application Deadline: November 22, 2019

Internal Application Requirements (all in PDF format)

  • Nominator’s Rationale for Nomination (200-word maximum): Explain why the nominee has been selected as the institutional nominee based on his/her strong record of significant independent scientific contributions, career success, and promise of sustained or accelerated progress in the future.
  • Nominee’s CV
  • Nominee’s Research Summary (1,000-word maximum): Describe up to five (5) of the nominee’s most significant scientific contributions and research accomplishments. Key results, their impact on the nominee’s field of study, and the nominee’s specific role in the described work should be included. Information about the nominee’s positions, awards, and service activities should be excluded. One figure illustrating the most significant results is allowed. Citations and figure caption do not count toward the word limit.

To access the online application, visit:


The nominee must:

  • Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a junior level Post-doctoral or Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

In the event that an Early-Career Scientist nominee has taken a maternity, paternity, adoptive, family care, military, or extended sick leave (in line with their current institution’s policies) during the 10 years since gaining their doctoral degree or equivalent, they can qualify for an extension of the eligibility timeframe. Instructions regarding how to request an extension are provided in the Requesting and Eligibility Exception section.

Individuals in receipt of current or prior research support from Takeda Pharmaceutical Company Limited, or its affiliates, are not eligible for nomination. This conflict of interest (COI) encompasses direct Takeda support/engagement with the nomination candidate, as well as direct Takeda support/engagement of a specific project or research that the nomination candidate is involved in.

Limited Submission Guidelines

Each institution may submit one nomination per year.

Review Criteria

  • Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
  • Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Novelty: The extent to which the work challenges existing paradigms, employs innovative new methodologies or concepts, and/or pursues an original question.
  • Promise: The extent to which the nominee has made innovative research contributions and shows exceptional promise for significant future achievement in the Award field.

Award Information

Number of Awards: 1

Award Amount: $200,000